The CosmoPHOS-nano Project is the world's largest R&D Project of Nanomedicine in Cardiology, consisting of 19 world-class Participants including 13 Universities and Research Foundations and 6 Companies, including BioContract.
Project title: Novel nanotechnology-enabled system for endovascular in vivo near-infrared fluorescence molecular imaging and endovascular near-infrared targeted photodynamic therapy of atherosclerotic heart disease.
Project cordinator Prof Seppo Ylä-Herttuala, Instytut A.I.Virtanen, Uniwersytet Wschodniej Finlandii
Duration of the project: march 2013 r. - marc 2018 r.
The CosmoPHOS-nano Project focuses on the development of a novel theranostic (diagnostic & therapeutic) nanotechnology-enabled portable combination system for human use, consisting of Nanomedicines and Medical Devices that interact with each other to enable: molecular imaging, targeted therapy, and real-time & follow-up therapy monitoring of Atherosclerotic Coronary Artery Disease (CAD) of the heart, which is the leading cause of human death and morbidity in Europe and worldwide.